台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    63.8
  • 漲跌
    ▼0.2
  • 漲幅
    -0.31%
  • 成交量
    33
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-永豐金-三重 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-三重 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/12162.6000.0063.801891.12%
2024/11/25164.2000.0065.401991.01%
2024/11/21163.3000.0063.301941.06%
2024/11/20167.8000.0064.401911.10%
2024/11/18170.6000.0070.701901.10%
2024/11/15171.40172.3072.6001010.00%
2024/11/14573.46172.0069.7041023.88%
2024/11/131.477.6100.0077.401.4971.43%
2024/10/240.296.7000.0096.500.21360.15%
2024/09/2000.000.497.0996.30-0.4139-0.30%
2024/09/1800.000.596.8696.20-0.5139-0.34%
2024/09/1600.000.197.5096.80-0.1139-0.07%
2024/09/1100.000.496.6796.10-0.4139-0.29%
2024/09/090.299.0000.0098.100.21370.15%
2024/09/040.199.4000.0099.500.11410.04%
2024/08/190106.5000.00106.0001300.01%
2024/08/150.1103.0000.00102.500.11140.04%
2024/08/090101.0000.00100.500930.03%
2024/08/070.2107.001.1107.32108.00-0.997-0.92%
2024/06/241101.0000.00100.5011390.72%
2024/06/170.1101.0000.00101.000.11460.03%
2024/06/071103.0000.00102.5011550.64%
2024/06/050.1103.0000.00102.500.11580.03%
2024/06/040.1103.0000.00103.000.11580.06%
2024/05/210.2103.0000.00102.000.21550.13%
2024/05/170.1105.0000.00105.500.11520.07%
2024/05/160106.0000.00107.0001500.02%
2024/05/151.1102.1200.00104.001.11480.71%
2024/05/140.1101.5000.00102.000.11440.03%
2024/05/130.1107.0000.00107.000.11270.08%
2024/05/100.1119.0000.00118.500.11200.04%
2024/05/080.1118.5000.00118.000.11190.04%
2024/05/060.1119.0000.00119.000.11180.04%
2024/05/030.3119.0000.00118.500.31170.21%
2024/04/300.1117.5000.00118.000.11160.04%
2024/04/230.1117.5000.00117.500.11150.04%
2024/04/1700.001114.50117.00-1111-0.89%
2024/04/160.1114.5000.00114.000.11110.05%
2024/04/120.1118.001117.50118.00-0.9104-0.90%
2024/04/110.1119.5900.00119.500.11010.11%
2024/04/1000.001127.00127.00-195-1.04%
2024/03/271.5121.3300.00122.001.5662.27%
2024/03/250.6123.9900.00124.000.6620.99%
2024/03/1900.000123.00123.000550.00%
2024/03/181124.0000.00124.001511.95%
2024/03/152120.5000.00121.502474.25%
2024/03/1400.000120.00119.00043-0.05%
2023/09/280114.0000.00114.000250.09%
2023/08/1000.000.1113.00112.50-0.130-0.17%
2023/04/120119.5000.00119.000420.08%
2023/04/070120.0000.00119.500360.05%
2023/03/2700.001119.00117.50-133-2.96%
2023/03/221115.5000.00115.501293.38%
2022/02/1100.000.1126.50128.00-0.120-0.43%
2022/01/0300.001127.00125.50-129-3.41%
2021/11/1100.000.3124.00124.00-0.329-0.94%
2021/11/0900.000.4126.00124.50-0.429-1.29%
2021/10/2100.000128.50127.50037-0.03%
2021/10/0600.001139.50140.00-134-2.86%
2021/10/050140.0000.00139.500350.03%
2021/10/011138.0000.00138.501352.81%
2021/09/231142.0000.00142.001342.92%
2021/09/2200.000.1143.50143.00-0.134-0.33%
2021/09/1000.000.1142.00143.50-0.134-0.15%
2021/09/081142.5000.00141.001342.88%
2021/08/240145.0000.00144.000350.03%
2021/08/0400.001139.00144.00-136-2.72%
2021/08/031155.0000.00156.001352.80%
2021/04/290.1148.0000.00147.500.1380.26%
2021/03/2600.000.2140.00141.00-0.227-0.62%
2021/03/040.1129.0000.00129.000.1260.30%
2021/02/2400.000.1127.00126.00-0.126-0.38%
2021/02/1700.000123.50123.50029-0.08%
2021/01/150.1123.5000.00123.500.1340.26%
2020/11/3000.001121.50121.50-131-3.18%
2020/08/3100.001116.00114.00-158-1.72%
2020/07/1400.001107.00107.00-163-1.58%
2020/07/0900.001107.50107.50-163-1.59%
2020/07/0300.001108.00107.50-162-1.60%
2020/06/233114.3300.00115.003575.26%
2020/06/221114.5000.00114.501541.82%
2020/03/2600.00195.6095.50-140-2.44%
2020/03/20185.0000.0084.501382.58%
2019/12/2700.002102.00102.00-220-9.93%
2019/07/122101.5000.00102.002464.34%
2019/04/0800.000.1108.50108.50-0.135-0.19%
2018/10/0900.004102.00101.50-443-9.22%
2018/09/072106.5000.00106.002523.78%
2018/07/1000.000.7123.00124.00-0.784-0.88%
2018/06/0600.002127.50127.50-2122-1.64%
2018/05/141125.0000.00126.0011310.76%
2018/05/101128.0000.00128.5011270.79%
2018/04/0900.002128.00127.00-2164-1.22%
2018/03/272128.5000.00129.0021631.22%
2018/03/211127.0000.00128.5011830.54%
2018/01/252124.5000.00123.5021611.24%
2018/01/191128.001129.00124.0001480.00%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音